Brief: Amneal Receives U.S. FDA Approval Of New Drug Application For Pyridostigmine Bromide Extended-Release Tablets
21/10/2024 16:27
Oct 21 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O :
* AMNEAL RECEIVES U.S. FDA APPROVAL OF NEW DRUG APPLICATION
FOR
PYRIDOSTIGMINE BROMIDE EXTENDED-RELEASE TABLETS
Source text for Eikon: ID:nBw6hFfMra
Further company coverage: AMRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-3M Company, Constellation Energy, Metropolitan Bank Holding
US FDA is working with manufacturers to boost estrogen patch supply amid access concerns (updated)
U.S. RESEARCH ROUNDUP- Intuit, MongoDB, Zscaler
U.S. STOCKS ON THE MOVE-Mastercard, Yum, Equinix
Amneal Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary